Physician profile
Jishu Motta
NPI 1689115867
$35,836.25
in general payments reported to CMS, 2019-2025
12 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $535 · 2022: $531 · 2023: $489 · 2024: $19K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $23K · Food and Beverage: $8,690 · Travel and Lodging: $2,827 · Education: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $22,500.00 |
| Food and Beverage | $8,689.98 |
| Travel and Lodging | $2,827.08 |
| Education | $752.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,678.99 | 2021-2025 | Tacticath, Assurity, Aveir |
| Medtronic, INC. | $9,587.50 | 2022-2025 | Micra, Azure Xt Dr Mri Surescan, Affera Mapping System |
| Boston Scientific Corporation | $6,842.98 | 2023-2025 | Watchman Access System, Farapulse |
| Biosense Webster, INC. | $4,258.04 | 2024-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Biotronik INC. | $1,916.87 | 2023-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Astrazeneca Pharmaceuticals Lp | $319.51 | 2021-2022 | |
| Amgen INC. | $104.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $42.41 | 2024-2025 | |
| Pfizer INC. | $27.00 | 2023 | |
| Janssen Pharmaceuticals, INC | $22.42 | 2024 | Xarelto |
| Philips North America LLC | $19.28 | 2025 | Lm Undivided |
| Cordis US Corp. | $16.90 | 2024 | Selution Slrptca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jishu Motta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.